This hypothesis would require further investigation, but is supported by observations that the MCL1 gene is more frequently amplified and overexpressed in ER+ breast cancers as compared to genes encoding all other Bcl-2 family members combined [11]. This evidence concerns the gene BCL2 and breast carcinoma.